InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.33
(
-0.07%
)
Bitcoin
60,867.53
(
-0.95%
)
Post# of 6
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

mlkrborn

Send PM Follow Ignore
Followers 40
Posts 7682
Boards Moderated 1
Alias Born 01/04/2006

mlkrborn

Re: None

Tuesday, 06/26/2012 10:50:49 AM

Tuesday, June 26, 2012 10:50:49 AM

Post# of 6
Helix BioPharma approves the selection of Director Robert Verhagen as CEO; plans to voluntarily delist from NYSE MKT (HBP) 1.40 : Co announces that its Board has approved the selection of Robert Verhagen as Chief Executive Officer. Verhagen is currently a Director for co. Co also announces that the Board has approved the voluntarily delisting of Helix's common shares from the NYSE MKT. The common shares will continue to trade on the Toronto Stock Exchange under the ticker symbol HBP and the co will continue to file the necessary reports with Canadian Securities.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up